You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tangningtongluo tablets

Showing 1 - 25 of 4,042
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type2 Diabetes, Diabetic Retinopathy Trial in China (Tangningtongluo tablets, Calcium dobesilate capsules)

Recruiting
  • Type2 Diabetes
  • Diabetic Retinopathy
  • Tangningtongluo tablets
  • Calcium dobesilate capsules
  • Chongqing, Chongqing, China
  • +9 more
Jun 27, 2022

Diabetic Foot Ulcer Trial in Nantong (Standardized Western Medicine Treatment, Tangningtongluo tablet and cream, Tangningtongluo

Recruiting
  • Diabetic Foot Ulcer
  • Standardized Western Medicine Treatment
  • +3 more
  • Nantong, Jiangsu, China
    Gu Yunjuan
Mar 4, 2022

Prediabetes Trial in Xiamen (Tangningtongluo tablet, lifestyle intervention)

Recruiting
  • Prediabetes
  • Tangningtongluo tablet
  • lifestyle intervention
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Mar 8, 2022

Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)

Not yet recruiting
  • Alcohol Use Disorder
  • Prazosin + cyproheptadine
  • KT110
  • (no location specified)
Nov 27, 2023

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Grayslake, Illinois
    Acpru /Id# 259897
Oct 2, 2023

Ankylosing Spondylitis Trial in China (Jitongning tablets, a simulated agent of Jitongning tablets)

Recruiting
  • Ankylosing Spondylitis
  • Jitongning tablets
  • a simulated agent of Jitongning tablets
  • Beijing, Beijing, China
  • +9 more
Aug 17, 2023

Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)

Not yet recruiting
  • Viral Infection COVID-19
  • Saint Petersburg,, Russian Federation
    Limited Liability Company "Research Center Eco-Safety"
Oct 23, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Toluca Lake, California
  • +101 more
Oct 9, 2023

Healthy Participants Trial (Sotorasib)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Sep 25, 2023

Elderly Subjects With Underlying Diseases Trial in Shanghai (Deuremidevir Hydrobromide Tablets)

Completed
  • Elderly Subjects With Underlying Diseases
  • Deuremidevir Hydrobromide Tablets
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 16, 2023

Primary IgA Nephropathy Trial (HRS-5965, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Nov 14, 2023

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)

Completed
  • Helicobacter Pylori Infection
  • Chang chun, Jilin, China
    The First Hospital of Jilin University
Oct 7, 2023

Type 2 Diabetes Trial (ARM A, ARM B, ARM C)

Not yet recruiting
  • Type 2 Diabetes
  • ARM A
  • +5 more
  • (no location specified)
Dec 27, 2022

Gout With Hyperuricemia in Adults Trial (HR091506 tablets + of febuxostat tablets, febuxostat tablets + of HR091506 tablets)

Not yet recruiting
  • Gout With Hyperuricemia in Adults
  • HR091506 tablets + placebo of febuxostat tablets
  • febuxostat tablets + placebo of HR091506 tablets
  • (no location specified)
Nov 15, 2023

Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)

Not yet recruiting
  • Healthy
  • Daridorexant 10 mg
  • Daridorexant 25 mg
  • (no location specified)
Jun 1, 2023

Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

Completed
  • Melanoma
  • +3 more
  • Binimetinib Oral Tablet
  • Rennes, France
    Biotrial
Mar 31, 2023

Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine

Not yet recruiting
  • Essential Hypertension
  • Azilsartan Medoxomil Potassium Tablet
  • +2 more
  • (no location specified)
Jul 21, 2023

Hearing Loss, Tinnitus, Sensorineural Hearing Loss Trial (Prednisone tablet, Ginkgo Biloba Extract)

Not yet recruiting
  • Hearing Loss
  • +2 more
  • Prednisone tablet
  • Ginkgo Biloba Extract
  • (no location specified)
Nov 8, 2023

Healthy Volunteers Trial in Grayslake (Venetoclax)

Recruiting
  • Healthy Volunteers
  • Grayslake, Illinois
    Acpru /Id# 255783
Jun 21, 2023

Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction Trial in Guangzhou (SHR7280

Not yet recruiting
  • Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
  • SHR7280 tablets
  • SHR7280 dry suspension
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
May 11, 2023

Type 2 Diabetes Trial (hrx0701 tablets?Metformin HCl tablets?Retagliptin phosphate tablets, hrx0701 tablets)

Completed
  • Type 2 Diabetes Mellitus
  • hrx0701 tablets、Metformin hydrochloride tablets、Retagliptin phosphate tablets
  • hrx0701 tablets
  • Changsha, Hunan, China
    Xiangya Third Hospital
Dec 20, 2022

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)

Not yet recruiting
  • Epilepsy
  • Lacosamide Tablets
  • Lacosamide extended release tablets
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023

Healthy Volunteers Trial in Changsha (TY-9591 Tablets under Fasted Condition - Arm1, Osimertinib Mesylate Tablets under Fasted

Completed
  • Healthy Volunteers
  • TY-9591 Tablets under Fasted Condition - Arm1
  • +5 more
  • Changsha, Hunan, China
    Hunan Provincial Tumor Hospital
Dec 6, 2022